Login
Super Investors / iShares Micro-Cap ETF

iShares Micro-Cap ETF

Ishares Trust · net assets $1.21B · 1311 holdings as of March 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 82.6% · STIV: 17.4% · OTHER: 0.0% · DE: 0.0% · EP: 0.0%

Financial position

Total assets
$1.47B
Total liabilities
$254M
Net assets
$1.21B
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$87.2K

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $133M $67M $24.5M
Reinvestment $0 $0 $0
Redemptions $0 $75.4M $32.4M
Net realized gain (non-derivative) $5.63M $36.8M $1.24M
Net unrealized appreciation (non-derivative) $54.2M $-24.6M $-64.3M

The three months of the reporting period, as filed; month 3 ends March 31, 2026.

Filing details

Registrant
Ishares Trust
Registrant CIK
1100663
Registrant LEI
5493000860OXIC4B5K91
Series
iShares Micro-Cap ETF
Series ID
S000004439
Series LEI
549300RWAE45TBJ0XD47
SEC file number
811-09729
Address
400 Howard Street, San Francisco, US-CA, 94105, US
Phone
800-474-2737
Form
NPORT-P
Filed
May 28, 2026
Report period ends
March 31, 2026
Report month ends
March 31, 2026
Accession number
000207169126012463
Holding Value % of net assets
Blackrock Funds Iii STIV $252M 20.79%
Praxis Precision Medicines, Inc. EC $21M 1.73%
Applied Digital Corp. EC $14.2M 1.17%
Applied Optoelectronics, Inc. EC $14.1M 1.16%
Cogent Biosciences, Inc. EC $13.9M 1.14%
Terns Pharmaceuticals, Inc. EC $12.7M 1.05%
Terawulf, Inc. EC $11.3M 0.93%
Energy Fuels, Inc. EC $10.8M 0.89%
Cipher Digital, Inc. EC $10.5M 0.87%
Celcuity, Inc. EC $10.1M 0.83%
Vistance Networks, Inc. EC $10M 0.82%
Tutor Perini Corp. EC $8.67M 0.71%
Erasca, Inc. EC $7.74M 0.64%
Gpgi, Inc. EC $7.7M 0.63%
Dianthus Therapeutics, Inc. EC $7.59M 0.63%
Axt, Inc. EC $7.49M 0.62%
Centrus Energy Corp. EC $7.38M 0.61%
Nlight, Inc. EC $6.84M 0.56%
Liquidia Corp. EC $6.23M 0.51%
Perpetua Resources Corp. EC $6.15M 0.51%
Tango Therapeutics, Inc. EC $5.86M 0.48%
Immunome, Inc. EC $5.63M 0.46%
Astronics Corp. EC $5.25M 0.43%
Adaptive Biotechnologies Corp. EC $5.23M 0.43%
Bel Fuse, Inc. EC $5.19M 0.43%
Hycroft Mining Holding Corp. EC $4.9M 0.40%
Amprius Technologies, Inc. EC $4.9M 0.40%
Oruka Therapeutics, Inc. EC $4.77M 0.39%
Definium Therapeutics, Inc. EC $4.69M 0.39%
Dave, Inc. EC $4.55M 0.37%
Blue Bird Corp. EC $4.54M 0.37%
Digi International, Inc. EC $4.52M 0.37%
Navitas Semiconductor Corp. EC $4.5M 0.37%
Ceco Environmental Corp. EC $4.43M 0.36%
Ducommun, Inc. EC $4.25M 0.35%
A10 Networks, Inc. EC $4.19M 0.35%
Thermon Group Holdings, Inc. EC $4.13M 0.34%
Axogen, Inc. EC $4.03M 0.33%
Artivion, Inc. EC $4.03M 0.33%
Stoke Therapeutics, Inc. EC $4.02M 0.33%
Turning Point Brands, Inc. EC $4.02M 0.33%
Viridian Therapeutics, Inc. EC $4.01M 0.33%
Ichor Holdings Ltd. EC $3.99M 0.33%
Nurix Therapeutics, Inc. EC $3.97M 0.33%
American Superconductor Corp. EC $3.93M 0.32%
Enliven Therapeutics, Inc. EC $3.89M 0.32%
Bigbear.ai Holdings, Inc. EC $3.85M 0.32%
Alumis, Inc. EC $3.81M 0.31%
Enviri Corp. EC $3.76M 0.31%
Diversified Healthcare Trust EC $3.67M 0.30%
Select Water Solutions, Inc. EC $3.65M 0.30%
National Energy Services Reunited Corp. EC $3.64M 0.30%
Interface, Inc. EC $3.64M 0.30%
Kodiak Sciences, Inc. EC $3.64M 0.30%
Ellington Financial, Inc. EC $3.63M 0.30%
Arlo Technologies, Inc. EC $3.62M 0.30%
Qcr Holdings, Inc. EC $3.52M 0.29%
Bank First Corp. EC $3.51M 0.29%
Red Cat Holdings, Inc. EC $3.42M 0.28%
Dime Community Bancshares, Inc. EC $3.4M 0.28%

Showing top 60 of 1311 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support